Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Luminal Gastroenterology
-
31 min
1. Novel treatments for GI malignancies- Prof. Bert H. O'Neil
-
40 min
2. The spectrum of GERD implications for assessment and management- Prof. Eamonn M. M. Quigley
-
54 min
3. Oro-pharyngeal and esophageal motility and dysmotility- Dr. John E. Pandolfino
-
55 min
4. Eosinophilic esophagitis and other non-reflux esophageal disorders- Prof. David Katzka
-
39 min
-
17 min
-
48 min
-
48 min
8. Gastric cancer, gastritis and the role of H. pylori- Prof. Anthony Axon
-
48 min
9. Celiac disease- Prof. Ciaran Kelly
-
43 min
10. IBD for the non-gastroenterologist- Prof. Sunanda Kane
-
34 min
11. The enteric microbiota in health and disease- Dr. Francisco Guarner
-
45 min
12. Colorectal cancer and hereditary colon cancer syndromes- Prof. Carol A. Burke
-
39 min
13. The spectrum of GI ischemia 1- Prof. Lawrence J. Brandt
-
31 min
14. The spectrum of Gl ischemia 2- Prof. Lawrence J. Brandt
-
41 min
15. Constipation and defecation disorders- Prof. Satish S. C. Rao
-
40 min
16. Diverticular disease of the colon- Dr. Dale Vimalachandran
-
73 min
17. Irritable bowel syndrome (IBS)- Prof. Eamonn M. M. Quigley
-
27 min
18. Evidence-based management of non-variceal upper GI bleeding- Prof. Joseph J. Sung
- Hepatology
-
32 min
19. Hepatitis B virus (HBV)- Prof. Marco Olivera-Martinez
-
26 min
20. Hepatitis C - cure of infection- Prof. Mark Mailliard
-
46 min
21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI- Prof. James H. Lewis
-
26 min
22. Drug-induced liver injury: risk factors and drug development in DILI- Prof. James H. Lewis
-
39 min
23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI- Prof. James H. Lewis
-
22 min
24. Portal hypertension- Prof. John Reinus
-
55 min
25. Portal hypertension: at the bedside- Dr. Clara Y. Tow
-
29 min
26. The management of chronic liver disease, including transplantation 1- Prof. Timothy M. McCashland
-
21 min
27. The management of chronic liver disease, including transplantation 2- Prof. Timothy M. McCashland
-
34 min
28. Hereditary hemochromatosis: what have we learnt from population studies- Prof. John K. Olynyk
-
38 min
29. Immune-mediated liver disease- Dr. Jenny Heathcote
-
51 min
30. Alcoholic liver disease- Prof. Michael Lucey
- The Pancreas and Biliary Tree
-
46 min
31. Acute pancreatitis- Prof. Davor Štimac
-
49 min
32. Chronic pancreatitis- Prof. Christopher Forsmark
-
47 min
33. Pancreatic cancer- Prof. Randall Brand
-
20 min
- Archived Lectures *These may not cover the latest advances in the field
-
52 min
35. The management of other aspects of chronic liver disease, including transplantation- Prof. Timothy M. McCashland
-
38 min
36. Chronic viral hepatitis B and C- Prof. Mark Mailliard
-
41 min
37. Pancreatic cancer- Prof. Randall Brand
-
72 min
38. Acute viral hepatitis- Prof. Geoffrey Dusheiko
-
33 min
39. Diverticular disease- Dr. Charles Knowles
-
57 min
40. The spectrum of gastrointestinal ischemia: 2010- Prof. Lawrence J. Brandt
-
51 min
41. Acute pancreatitis- Prof. Davor Štimac
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Variceal bleeding
- Varices increase in diameter progressively
- Beta blocker prevention of first variceal hemorrhage
- Variceal hemorrhage
- Variceal bleeding pearls
- Ascites
- Ascites management
- Hepatorenal syndrome
- Hepatorenal survival
- HRS treatment
- Vasoconstrictors and HRS
- West Haven classification of HE
- Precipitants of HE
- Rifaximin vs. nonabsorbable disaccharides
- Hepatopulmonary syndrome
- Hepatopulmonary syndrome survival rate
- Transplantation outcome in HPS patients
- Portopulmonary hypertension
- PPHTN: liver transplantation
- Evaluation/preparation for liver transplantation (1)
- Evaluation/preparation for liver transplantation (2)
- Alcohol and transplantation
- Hepatitis B
- Hepatitis C treatment prior to transplantation
- NASH/metabolic syndrome
- Liver transplantation for HCC: Milan criteria
- UCSF criteria for HCC
- Listing criteria for liver transplantation
- Liver allocation MELD score
- Mortality risk according to MELD
- Change to inactive status
- Medical conditions after liver transplantation
- Biliary endoscopy
- Fluoroscopic view of ERCP: anastomotic strictures
- Fluoroscopic view of ERCP: biliary leaks
- Biliary casts - endoscopy
- GI related disorders
- Inflammatory bowel disease
- Colon cancer, IBD, PSC and transplantation
- Annual examinations
- Vaccination
- Obesity
- Bone disease
- Bone disease recommendations
- Cardiovascular disease
- Cardiovascular recommendations
- Diabetes
- Patient/graft survival in patients with or W/O DM
- CRF after solid organ transplantation
- Renal disease
- De novo malignancy
- Long-term causes of death
- Drug interactions in transplantation medications
- Future prospects
Topics Covered
- Common complications of end stage cirrhosis including life threatening disorders of variceal bleeding, ascites, hepatorenal syndrome, encephalopathy and hepatopulmonary syndrome
- Preparation for listing for liver transplantation in patients with end stage liver disease includes documentation and absence of alcohol consumption (in alcoholics), reduction of hepatitis B DNA levels (in HBV patients) and aggressive treatment of hepatocellular carcinoma to reduce the risk of recurrent disease
- The most common allocation system for liver transplantation is the model for end stage liver disease
- Post transplantation care of the patient requires diligent annual followup with concentration on common diseases which include: metabolic syndrome (diabetes mellitus, obesity, hypertension, hyperlipidemia), Preventive medicine (vaccination, dental disease), Inflammatory bowel disease, bone disease, and renal dysfunction
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
McCashland, T.M. (2011, January 5). The management of other aspects of chronic liver disease, including transplantation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 28, 2025, from https://doi.org/10.69645/JATB8280.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Timothy M. McCashland has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The management of other aspects of chronic liver disease, including transplantation
A selection of talks on Clinical Practice
Hide